Efficacy and Safety of Transcranial Electric Stimulation during the Perinatal Period: A Systematic Literature Review and Three Case Reports

Abstract

Introduction: The perinatal period is an at-risk period for the emergence or decompensation of psychiatric disorders. Transcranial electrical stimulation (tES) is an effective and safe treatment for many psychiatric disorders. Given the reluctance to use pharmacological treatments during pregnancy or breastfeeding, tES may be an interesting treatment to consider. Our study aims to evaluate the efficacy and safety of tES in the perinatal period through a systematic literature review followed by three original case reports. Method: Following PRISMA guidelines, a systematic review of MEDLINE and ScienceDirect was undertaken to identify studies on tES on women during the perinatal period. The initial research was conducted until 31 December 2021 and search terms included: tDCS, transcranial direct current stimulation, tACS, transcranial alternating current stimulation, tRNS, transcranial random noise stimulation, pregnancy, perinatal, postnatal, and postpartum. Results: Seven studies reporting on 33 women during the perinatal period met the eligibility criteria. No serious adverse effects for the mother or child were reported. Data were limited to the use of tES during pregnancy in patients with schizophrenia or unipolar depression. In addition, we reported three original case reports illustrating the efficacy and safety of tDCS: in a pregnant woman with bipolar depression, in a pregnant woman with post-traumatic stress disorder (sham tDCS), and in a breastfeeding woman with postpartum depression. Conclusions: The results are encouraging, making tES a potentially safe and effective treatment in the perinatal period. Larger studies are needed to confirm these initial results, and any adverse effects on the mother or child should be reported. In addition, research perspectives on the medico-economic benefits of tES, and its realization at home, are to be investigated in the future.

The effect of transcranial alternating current stimulation on functional recovery in patients with stroke: a narrative review

“…Second, tACS is portable and can be used in a home setting ( 25 ). Third, tACS is safe and does not cause any serious adverse events ( 39 ). Therefore, tACS appears to be a readily available and safe alternative therapeutic approach to improve brain function.…”

The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study

“…These changes may potentially affect seizure frequency and fetal exposure to ASMs, and even carry the risk of teratogenic effects ( 78 , 79 ). Laurin et al ( 80 ) presented three case reports demonstrating that tDCS appears to be a safe and effective treatment for many mental disorders in the perinatal period, including depression and post-traumatic stress disorder. Pregnant patients with treatment-resistant depression exhibited favorable tolerability to rTMS, with more than 50% of patients in the intervention group showing improved mood after the treatment period ended ( 81 ).…”

Transcranial magnetic stimulation and transcranial direct current stimulation in reducing depressive symptoms during the peripartum period

“…tDCS involves a low-intensity electrical current between at least two scalp electrodes (the anode and the cathode) to modulate neurons’ membrane firing threshold [54–56]. As in rTMS, the use of tDCS in PPD is motivated by its ability to modulate DLPFC hypofunction in depression [57,58 ▪▪ ].…”